This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Molecular Genetics and Clinical Implications of CMT1A and HNPP

James R. Lupski, MD, PhD; Phillip F. Chance, MD; Carlos A. Garcia, MD

JAMA. 1993;270(19):2326-2330.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CHARCOT-MARIE-TOOTH disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP) are autosomal dominant, inherited primary demyelinating peripheral neuropathies that appear to result from reciprocal DNA duplication/deletion, respectively, of a 1.5-megabase (Mb) pair region on chromosome 17p. While inherited DNA rearrangements are present in most CMT1A and HNPP patients, new mutation duplication or deletion can be responsible for sporadic cases of CMT1A or HNPP. This critical 1.5-Mb region is likely to contain multiple genes, but a dosage effect of one gene that encodes a myelin protein of the peripheral nerve (PMP22) appears to play a critical role in the disease phenotype. Moreover, PMP22 point mutations associated with CMT1A have been identified in patients who do not have the CMT1A duplication. The recent elucidation of the molecular mechanisms for CMT1A and HNPP has important clinical implications for the diagnosis, prognosis, genetic counseling, and rational approaches to therapy for . . . [Full Text PDF of this Article]

Author Affiliations
From the Institute for Molecular Genetics, the Department of Pediatrics, and the Human Genome Center, Baylor College of Medicine, and the Texas Children's Hospital, Houston (Dr Lupski); the Division of Medical Genetics, Department of Pediatrics, University of Utah Medical Center, Salt Lake City (Dr Chance); and the Departments of Neurology and Pathology, Louisiana State University School of Medicine, New Orleans (Dr Garcia). Dr Chance is now at the Division of Neurology, Children's Hospital of Philadelphia, Pa.

Footnotes
Reprint requests to the Institute for Molecular Genetics, Baylor College of Medicine, One Baylor Plaza, Anderson 609E, Houston, TX 77030 (Dr Lupski).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?